Site 0203 - Texas Oncology — Tyler, Texas

Site 0203 - Texas Oncology is a clinical research site located in Tyler, Texas, United States 75702.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Site 0203 - Texas Oncology has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Sponsors: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Tyler

Browse all research sites in Texas · View every site in Tyler

• University of Texas Health Center at Tyler - Titus Regional Hospital
• Mother Frances Hospital
• The University of Texas Health Science Center at Tyler/HOPE Cancer Center
• The University of Texas Health Science at Tyler
• Trinity Mother Frances Hospitals and Clinics
• The University of Texas Health Science Center at Tyler on behalf of UT Health East Texas HOPE Cancer
• The University of Texas Health Science Center at Tyler - Pulmonology
• The University of Texas Health Science Center at Tyler Center for Clinical Research
• The University of Texas Health Science Center
• Christus Mother Frances Hospital
• Christus Health Frances Hospital
• The University of Texas Health Center at Tyler

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site 0203 - Texas Oncology?

Site 0203 - Texas Oncology has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site 0203 - Texas Oncology conducted?

Site 0203 - Texas Oncology has 1 clinical trials on record, with 1 currently active. Their work covers High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Is Site 0203 - Texas Oncology accredited by Crixeo Clinical Trials?

Site 0203 - Texas Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site 0203 - Texas Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.